Pirmenol inhibits muscarinic acetylcholine receptor-operated K+ current in the guinea pig heart

European Journal of Pharmacology

Volumn 338, Issue 1, 1997, Pages 71-74

  Watanabe, Yasuhide ^a   Hara, Yukio ^a   Tamagawa, Masaji ^a   Nakaya, Haruaki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Disopyramide; K+ current; Muscarinic acetylcholine receptor operated (I(K.ACh)); Pirmenol

Indexed keywords

CARBACHOL; DISOPYRAMIDE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRMENOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HEART ATRIUM FIBRILLATION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; REPOLARIZATION;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARBACHOL; DISOPYRAMIDE; ELECTRIC STIMULATION; GUINEA PIGS; HEART; PATCH-CLAMP TECHNIQUES; PIPERIDINES; POTASSIUM CHANNELS; RECEPTORS, MUSCARINIC;

EID: 0030714682     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01300-9     Document Type: Article

References (13)

1. Atarashi H., Kuruma A., Ino T., Nirayama Y., Saitoh H., Hayakawa H. Clinical effects and pharmacokinetics of a single oral dose of pirmenol hydrochloride. J. Cardiovasc. Pharmacol. 27:1996;556-562.
2. Chang T. Preclinical and clinical pharmacokinetics of pirmenol. Am. J. Cardiol. 59:1987;15H-19H.
3. 3 receptors. J. Cardiovasc. Pharmacol. 19:1992;674-681.
4. Hara Y., Nakaya H. SD-3212, a new class I and IV antiarrhythmic drug: A potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells. Br. J. Pharmacol. 116:1995;2750-2756.
5. + channels in rabbit atrium. J. Physiol. London. 433:1990;589-613.
6. Mori K., Hara Y., Saito T., Masuda Y., Nakaya H. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms. Circulation. 91:1995;2834-2843.
7. Nakajima T., Kurachi Y., Ito H., Sugimoto T. Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: Mediation by different molecular mechanisms. Circ. Res. 64:1989;297-303.
8. Nakaya H., Tohse N., Kanno M. Frequency- and voltage-dependent depression of maximum upstroke velocity of action potentials by pirmenol in guinea pig ventricular muscles. Jpn. J. Pharmacol. 48:1988;423-434.
9. Ruffy, R., 1995. Atrial fibrillation. In: Zipes, D.P., Jalife, J. (Eds.), Cardiac Electrophysiology: From Cell to Bedside, 2nd ed. W.B. Saunders, Philadelphia, PA, pp. 682-690.
10. Reichardt B., Konzen G., Hauswirth O. Pirmenol, a new antiarrhythmic drug with potassium- and sodium-channel blocking activity: A voltage-clamp study in rabbit Purkinje fibers. Naunyn-Schmiedebergs Arch. Pharmacol. 341:1990;462-471.
11. Von Euler D.E., Scanlon P.J. Acetylcholine release by a stimulus train lowers atrial fibrillation threshold. Am. J. Physiol. 253:1987;H863-H868.
12. Watanabe Y., Hara Y., Tamagawa M., Nakaya H. Inhibitory effect of amiodarone on muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells. J. Pharmacol. Exp. Ther. 279:1996;617-624.
13. Wu S.N., Nakajima T., Yamashita T., Hamada E., Hazami H., Iwasawa K., Omata M., Kurachi Y. Molecular mechanism of cibenzoline-induced anticholinergic action in single atrial myocytes. J. Cardiovasc. Pharmacol. 23:1994;618-623.